FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office
This article was originally published in The Gray Sheet
Executive Summary
Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”